TETmedical

Fair Haven, NJ · Founded 2021 · Privately Held (backing)

Developer of an in vitro diagnostic nanomedicine platform designed for clinical diagnostic use. TETmedical is based in Fair Haven, NJ and was founded in 2021. Its last reported valuation was $10.5 million in Feb 2024. It has raised $4 million across 2 recorded rounds; the latest was a $3.5 million seed round in Jun 2026.

Last reported valuation
$10.5M
Oct 2026
Priced at
—
Total raised
$4.0M
Last round
Seed Round
Jun 2026

TETmedical key facts

as of Oct 2026
  • Developer of an in vitro diagnostic nanomedicine platform designed for clinical diagnostic use.
  • TETmedical is valued at approximately $10.5M as of Oct 2026 (last reported valuation).
  • It has raised $4.0M across 2 recorded rounds; the latest was Seed Round ($3.5M) in Jun 2026.
  • Notable investors include National Institutes of Health, Bantam Group, New York Ventures, Launchpad Venture Group, SideCar Angels — 11 tracked in total.
  • TETmedical has filed 1 Form D with the SEC, most recently Jun 2023 ($2.5M sold to 70 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$10.5M

TETmedical's last reported valuation, Feb 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of TETmedical with a free account
  • ·The complete investor list: 11 names
  • ·Watch TETmedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

TETmedical funding rounds

2 rounds
Jun 2026Seed Round$3.5MSEC filing▮
May 2023Seed Round$2.5MSEC filing▮

TETmedical valuation

TETmedical's last reported valuation was $10.5 million in Feb 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has TETmedical raised?

TETmedical has raised $4 million across 2 recorded rounds since 2023. The largest was a $3.5 million seed round in Jun 2026.

TETmedical has filed 1 Form D with the SEC, most recently in Jun 2023 ($2.5 million sold to 70 investors).

TETmedical investors

11 investors are on record for TETmedical, including National Institutes of Health, Bantam Group, New York Ventures and Launchpad Venture Group. The seed round in Jun 2026 drew 45 investors.

About TETmedical

Developer of an in vitro diagnostic nanomedicine platform designed for clinical diagnostic use. The company's platform uses tethered enzymes bound to silica nanoparticles to form a stable molecular system capable of rapid catalytic reactions, high analytical sensitivity, and compatibility with standard laboratory plate readers, enabling hospital and emergency department diagnostics to support time-sensitive disease assessment, biomarker detection across proteins, enzymes, viruses, and microRNAs, and informed clinical decision making with reduced uncertainty.

Sector
Healthcare
HQ
Fair Haven, NJ, United States
Founded
2021
Employees
7
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.